ald

Documents about ald

• Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)#1396962ClinicalTrials.gov
• Comparison of ALD, NASH, and Healthy Control Patients#1293284ClinicalTrials.gov
• Early Diagnosis Of Childhood Cerebral ALD#841087ClinicalTrials.gov
• LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies#1162976ClinicalTrials.gov
• Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)#1308132ClinicalTrials.gov
• Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)#883074ClinicalTrials.gov
• Untersuchung und Optimierung eines plasmagestützten Ruthenium-ALD-Prozesses : Studienarbeit#683157DataCite
• Growth-induced mechanical gradients and directional stiffness in ultrathin low-temperature ALD alumina coatings#411887Infoscience
• Substrate-Enhanced Atomic Layer Deposition of Lithium Niobate on NMC Cathodes for Sulfide-Based All-Solid-State Batteries#1134174HAL (France)
• SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)#846743ClinicalTrials.gov
• Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia#1282918ClinicalTrials.gov
• Nucleation and growth dynamics of ultra-thin ALD layers for cathode protection in next-generation lithium batteries#147451HAL (France)
• MT2022-01: MSCs for ALD#897002ClinicalTrials.gov
• Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product#1498455ClinicalTrials.gov
• The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)#1280070ClinicalTrials.gov
• Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)#435823ClinicalTrials.gov
• Signatures of Dynes superconductivity in the THz response of ALD-grown NbN thin films#1355982arXiv (All)
• Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms#1459463HAL (France)
• Effect of Rapid Thermal Annealing on the Superconductivity of ALD-Grown TiN thin films#1536254arXiv (All)
• Modification of optical properties in ultrathin ALD-grown NbN layers using oxygen plasma treatment#1447920arXiv (All)
• Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)#1337750ClinicalTrials.gov
• Differential candidate characteristics associated with increasing ALD and MASH among liver transplant listings in the US.#148289NCBI PubMed Central
• Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy#1047026ClinicalTrials.gov
• Disease Outcomes in Boys with ABCD1 Variants Identified by Newborn Screening for X-ALD#417382bioRxiv / medRxiv
• Thermal Atomic Layer Deposition of Transition Metal Phosphide Thin Films#1071585Boise State ScholarWorks
• LIVER FIBROSIS PREVALENCE IN FRANCE#1422021ClinicalTrials.gov
• Tailoring ZnO thin films via ALD: Impact of cycle number on structural, optical, wettability, photocatalytic and morphological properties#288331HAL (France)
• Demonstrate of High-Performance Top-Gate ALD Crystalline In2O3 Transistor Enabled by Lattice-Matched HfO2 and In2O3 Heterostructure#1109189arXiv (OAI Expanded)
• ALD grown (001) κ-Ga2O3 epitaxial thin films on c-plane sapphire: influence of thickness and thermal annealing#1329216HAL (France)
• Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)#1352059ClinicalTrials.gov
• Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation#297004IRIS
• Improved degradation of acetaminophen with NiO-TiO2 nanofibers synthesized through atomic layer deposition#315043HAL (France)
• Effects of SAMe in Patients With Alcoholic Liver Disease#1150091ClinicalTrials.gov
• IT and IV Lentiviral Gene Therapy for X-ALD#1309686ClinicalTrials.gov
• MD1003-AMN MD1003 in Adrenomyeloneuropathy#854854ClinicalTrials.gov
• Development and validation of a disease-specific health-related quality of life questionnaire for alcohol-associated liver disease: The CLDQ-ALD.#232166NCBI PubMed Central
• RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)#1211122ClinicalTrials.gov
• Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis#1293360ClinicalTrials.gov
• TiO2/SnO2 photocatalysts by electrospinning and atomic layer deposition for pharmaceutical contaminant removal#318952HAL (France)
• Long-term performance of non-ALD MCP-PMTs in the high-radiation environment of ALICE#973677arXiv (All)
• Motivational Interviewing and Practice of Physical Activity in Patients With ALD#1183241ClinicalTrials.gov
• Multi-gate Si nanowire MOSFETs : fabrication, strain engineering and transport analysis#1361831DataCite
• A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN#1485366ClinicalTrials.gov
• A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy#833890ClinicalTrials.gov
• CM for Patients With ALD After Liver Transplant#841975ClinicalTrials.gov
• Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients#852427ClinicalTrials.gov
• Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)#1337952ClinicalTrials.gov
• Alterations of Gut Microbiota and Metabolites in ALD Patients#1280882ClinicalTrials.gov
• Silver-doped TiO₂/SnO₂ for enhanced visible-light-driven photocatalytic degradation of acetaminophen#218218HAL (France)
• Reactions of Bis(tert‑butylimino)bis(dimethylamino) Tungsten(VI) with molecular silanol, silica and silicon wafer : Analogy Between Molecular and Surface Chemistries relevant to ALD thin film growths from BTBMW#294705HAL (France)